Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Raras (20)

2024

  1. A FokI-driven signal amplification platform for the simultaneous detection of multiple viral RNA pathogens

    Sensors and Diagnostics, Vol. 3, Núm. 3, pp. 468-478

  2. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma

    eBioMedicine, Vol. 102

  3. Metformin and Glucose Concentration as Limiting Factors in Retinal Pigment Epithelial Cell Viability and Proliferation

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

2023

  1. A complex interplay between H2A.Z and HP1 isoforms regulates pericentric heterochromatin

    Frontiers in Cell and Developmental Biology, Vol. 11

  2. A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features

    Blood, Vol. 142, Núm. 20, pp. 1752-1756

  3. CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer

    Clinical Epigenetics, Vol. 15, Núm. 1

  4. Circulating miRNA expression in long-standing type 1 diabetes mellitus

    Scientific Reports, Vol. 13, Núm. 1

  5. Maternal obesity and gestational diabetes reprogram the methylome of offspring beyond birth by inducing epigenetic signatures in metabolic and developmental pathways

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  6. Multi-omic integration of DNA methylation and gene expression data reveals molecular vulnerabilities in glioblastoma

    Molecular Oncology, Vol. 17, Núm. 9, pp. 1726-1743

  7. Nicotinamide N-methyltransferase (NNMT) regulates the glucocorticoid signaling pathway during the early phase of adipogenesis

    Scientific Reports, Vol. 13, Núm. 1

  8. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

    Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895

  9. ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer

    Clinical Epigenetics, Vol. 15, Núm. 1

2022

  1. Aging and cancer epigenetics: Where do the paths fork?

    Aging Cell, Vol. 21, Núm. 10

  2. Enhanced Detection of Viral RNA Species Using FokI-Assisted Digestion of DNA Duplexes and DNA/RNA Hybrids

    Analytical Chemistry, Vol. 94, Núm. 18, pp. 6760-6770

2021

  1. Dna methylomes and epigenetic age acceleration associations with poor metabolic control in t1d

    Biomedicines, Vol. 9, Núm. 1, pp. 1-8

2017

  1. Multilayer OMIC Data in medullary thyroid carcinoma identifies the STAT3 pathway as a potential therapeutic target in RETM918T Tumors

    Clinical Cancer Research, Vol. 23, Núm. 5, pp. 1334-1345

2016

  1. Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development

    Leukemia, Vol. 30, Núm. 1, pp. 94-103

2015

  1. DNA methylation profiling in pheochromocytoma and paraganglioma reveals diagnostic and prognostic markers

    Clinical Cancer Research, Vol. 21, Núm. 13, pp. 3020-3030

  2. Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer

    Oncotarget, Vol. 6, Núm. 8, pp. 5903-5917

2012

  1. A DNA methylation fingerprint of 1628 human samples

    Genome Research, Vol. 22, Núm. 2, pp. 407-419